VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach

Barr, Martin P., O'Byrne, Kenneth J., Al-Sarraf, Nael, & Gray, Steven G. (2015) VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach. Epigenomics, 7(6), pp. 897-910.

View at publisher

Abstract

Aims:

To evaluate the potential therapeutic utility of histone deacetylase inhibitors (HDACi) in targeting VEGF receptors in non-small-cell lung cancer.

Materials & methods:

Non-small-cell lung cancer cells were screened for the VEGF receptors at the mRNA and protein levels, while cellular responses to various HDACi were examined.

Results:

Significant effects on the regulation of the VEGF receptors were observed in response to HDACi. These were associated with decreased secretion of VEGF, decreased cellular proliferation and increased apoptosis which could not be rescued by addition of exogenous recombinant VEGF. Direct remodeling of the VEGFR1 and VEGFR2 promoters was observed. In contrast, HDACi treatments resulted in significant downregulation of the Neuropilin receptors.

Conclusion:

Epigenetic targeting of the Neuropilin receptors may offer an effective treatment for lung cancer patients in the clinical setting.

Impact and interest:

0 citations in Scopus
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 95342
Item Type: Journal Article
Refereed: Yes
Keywords: epigenetics, pistons, neuropilins, VEGF, NSCLC
DOI: 10.2217/epi.15.51
ISSN: 1750-192X
Divisions: Current > Institutes > Institute of Health and Biomedical Innovation
Deposited On: 02 May 2016 23:53
Last Modified: 02 Aug 2016 22:40

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page